首页> 外文OA文献 >'Third drug' trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
【2h】

'Third drug' trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

机译:“第三种药物”试验:当血压仍然不受β受体阻滞剂和噻嗪类利尿剂控制时,加入抗高血压药的比较研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hydralazine, labetalol, methyldopa, minoxidil, prazosin, and placebo were compared when added by random allocation to atenolol 100 mg and bendrofluazide 5 mg daily in a series of 238 hypertensive patients inadequately controlled by the beta blocker-diuretic combination. Atenolol was withdrawn in those allocated to labetalol, and minoxidil was given only to men. The order of acceptability was: placebo, hydralazine, prazosin, methyldopa, minoxidil, labetalol. Minoxidil was more effective than the other active drugs, which had similar potency to one another. All the active agents were more effective than placebo. Hydralazine was the most generally suitable third drug, with prazosin a close second. Minoxidil was especially effective in patients with less severe hypertension but the same regimen caused fluid retention in those with more severe disease. Labetalol should probably be introduced at a low dose (150 mg daily) even when replacing full doses of a previously administered beta blocker.
机译:在238例受β受体阻滞剂-利尿剂联合治疗控制不充分的高血压患者中,随机分配每日服用100 mg阿替洛尔和5 mg苯达氟嗪时,比较了肼屈嗪,拉贝洛尔,甲基多巴,米诺地尔,哌唑嗪和安慰剂。在分配给拉贝洛尔的那些药物中撤回阿替洛尔,而米诺地尔仅给予男性。可接受的顺序为:安慰剂,肼苯哒嗪,哌唑嗪,甲基多巴,米诺地尔,拉贝洛尔。米诺地尔比其他活性药物更有效,后者具有相似的功效。所有活性剂均比安慰剂有效。肼屈嗪是最普遍适用的第三种药物,吡唑嗪紧随其后。米诺地尔在高血压较轻的患者中特别有效,但相同的治疗方案会使病情较重的患者出现积水。拉贝洛尔可能应该以低剂量(每天150毫克)引入,即使是替换之前服用的全剂量β受体阻滞剂也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号